A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
- Published In:
- The New England journal of medicine, 382(22), 2117-2128 (2020)
- Authors:
- Kelly, Aaron S(2), Auerbach, Pernille, Barrientos-Perez, Margarita, Gies, Inge, Hale, Paula M, Marcus, Claude, Mastrandrea, Lucy D, Prabhu, Nandana, Arslanian, Silva
- Database ID:
- RPEP-04902
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04902APA
Kelly, Aaron S; Auerbach, Pernille; Barrientos-Perez, Margarita; Gies, Inge; Hale, Paula M; Marcus, Claude; Mastrandrea, Lucy D; Prabhu, Nandana; Arslanian, Silva. (2020). A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.. The New England journal of medicine, 382(22), 2117-2128. https://doi.org/10.1056/NEJMoa1916038
MLA
Kelly, Aaron S, et al. "A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.." The New England journal of medicine, 2020. https://doi.org/10.1056/NEJMoa1916038
RethinkPeptides
RethinkPeptides Research Database. "A Randomized, Controlled Trial of Liraglutide for Adolescent..." RPEP-04902. Retrieved from https://rethinkpeptides.com/research/kelly-2020-a-randomized-controlled-trial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.